Covered recipient · General Payments record
CURTIS ROSEBRAUGH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$329,430.00
- Reported across 79 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $86,137.50 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $58,550.00 | 15 |
| Novo Nordisk AS | $14,950.00 | 1 |
| Acerta Pharma LLC | $7,200.00 | 3 |
| Esperion Therapeutics, Inc. | $5,437.50 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2,925.00 | 07/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973380 | CMS |
| ABBVIE INC. | $6,175.00 | 07/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973382 | CMS |
| ABBVIE INC. | $9,100.00 | 08/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973384 | CMS |
| ABBVIE INC. | $3,737.50 | 08/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973386 | CMS |
| ABBVIE INC. | $3,750.00 | 08/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973388 | CMS |
| ABBVIE INC. | $2,343.75 | 08/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973390 | CMS |
| ABBVIE INC. | $4,375.00 | 08/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973392 | CMS |
| ABBVIE INC. | $3,412.50 | 08/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973394 | CMS |
| ABBVIE INC. | $781.25 | 08/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973396 | CMS |
| ABBVIE INC. | $3,125.00 | 08/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973398 | CMS |
| ABBVIE INC. | $1,406.25 | 08/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973400 | CMS |
| ABBVIE INC. | $7,343.75 | 11/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973402 | CMS |
| ABBVIE INC. | $3,412.50 | 11/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973404 | CMS |
| ABBVIE INC. | $2,762.50 | 12/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973406 | CMS |
| ABBVIE INC. | $3,900.00 | 12/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105973408 | CMS |
| AstraZeneca Pharmaceuticals LP | $3,000.00 | 04/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105811331 | CMS |
| AstraZeneca Pharmaceuticals LP | $3,000.00 | 05/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105558708 | CMS |
| AstraZeneca Pharmaceuticals LP | $1,200.00 | 11/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104717331 | CMS |
| Esperion Therapeutics, Inc. | $2,625.00 | 03/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1129452920 | CMS |
| Esperion Therapeutics, Inc. | $750.00 | 03/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1129452922 | CMS |
| Esperion Therapeutics, Inc. | $1,500.00 | 07/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1129452924 | CMS |
| Esperion Therapeutics, Inc. | $562.50 | 09/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1129452926 | CMS |
| Novo Nordisk AS | $14,950.00 | 12/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1096553449 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.